Albert Von Der Assen

Georgsmarienhuette, NI 49124, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).

Acute and Long-Term Toxicity after Planned Intraoperative Boost and Whole Breast Irradiation in High-Risk Patients with Breast Cancer-Results from the Targeted Intraoperative Radiotherapy Boost Quality Registry (TARGIT BQR).

Journal: Cancers

Published: April 30, 2024

Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.

Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.

Journal: Biomedicines

Published: October 22, 2023

6q deletion is frequent but unrelated to patient prognosis in breast cancer.

6q deletion is frequent but unrelated to patient prognosis in breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: November 24, 2020

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.

Journal: Aging

Published: July 16, 2019

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.

A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.

Journal: Molecular carcinogenesis

Published: July 05, 2019

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 03, 2019

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.

p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.

Journal: Oncotarget

Published: May 04, 2016

8p deletion is strongly linked to poor prognosis in breast cancer.

8p deletion is strongly linked to poor prognosis in breast cancer.

Journal: Cancer biology & therapy

Published: May 12, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026